Sponsored by
I am proud to say I am on Duke's patient advocacy board. This program will help pay the expenses for children with brain tumors to be treated at, or even just to get a second opion, at Duke. We (the Musella Foundation) was one of the funders of the recombinant polio-rhinovirus immunotherapy for recurrent pediatric high-grade glioma mentioned in the article!